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ABSTRACT According to the World Health Organization (WHO), an estimated 257
million people worldwide are chronically infected with hepatitis B virus (HBV), with
approximately 15 million of them being coinfected with hepatitis D virus (HDV). To
investigate the prevalence and transmission of HBV and HDV within the general
population of a rural village in Cameroon, we analyzed serum samples from most
(401/448) of the villagers. HBV surface antigen (HBsAg) was detected in 54 (13.5%)
of the 401 samples, with 15% of them also containing anti-HDV antibodies. Al-
though Cameroon has integrated HBV vaccination into their Expanded Program on
Immunization for newborns in 2005, an HBsAg carriage rate of 5% was found in chil-
dren below the age of 5 years. Of the 54 HBsAg-positive samples, 49 HBV pre-S/S
sequences (7 genotype A and 42 genotype E sequences) could be ampliﬁed by PCR.
In spite of the extreme geographical restriction in the recruitment of study partici-
pants, a remarkable genetic diversity within HBV genotypes was observed. Phyloge-
netic analysis of the sequences obtained from PCR products combined with demo-
graphic information revealed that the presence of some genetic variants was
restricted to members of one household, indicative of intrafamilial transmission,
which appears to take place at least in part perinatally from mother to child. Other
genetic variants were more widely distributed, reﬂecting horizontal interhousehold
transmission. Data for two households with more than one HBV-HDV-coinfected in-
dividual indicate that the two viruses are not necessarily transmitted together, as
family members with identical HBV sequences had different HDV statuses.
IMPORTANCE This study revealed that the prevalence of HBV and HDV in a rural
area of Cameroon is extremely high, underlining the pressing need for the improve-
ment of control strategies. Systematic serological and phylogenetic analyses of HBV
sequences turned out to be useful tools to identify networks of virus transmission
within and between households. The high HBsAg carriage rate found among chil-
dren demonstrates that implementation of the HBV birth dose vaccine and improve-
ment of vaccine coverage will be key elements in preventing both HBV and HDV in-
fections. In addition, the high HBsAg carriage rate in adolescents and adults
emphasizes the need for identiﬁcation of chronically infected individuals and linkage
to WHO-recommended treatment to prevent progression to liver cirrhosis and hepa-
tocellular carcinoma.
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Despite being entirely vaccine preventable, hepatitis B virus (HBV) infection remainsa serious public health concern, with estimates of 257 million chronic HBV surface
antigen (HBsAg) carriers worldwide (1). Without treatment, disease will progress to liver
cirrhosis and hepatocellular carcinoma in 15 to 40% of the chronically infected patients.
According to WHO ﬁgures, about 60 million HBsAg carriers live in the WHO African
Region, the majority of whom are unaware of their infection and, thus, constitute a
reservoir for the inadvertent spread of the virus to others (2, 3). Transmission of HBV in
areas of high endemicity commonly occurs perinatally from mother to child or hori-
zontally by exposure to infected blood or other body ﬂuids. In African settings, the
predominant route of HBV transmission appears to be horizontal, in particular, from
child to child during the ﬁrst 5 years of life due to close interaction with infected
household contacts and playmates (1). HIV-HBV coinfection seems to lead to an
increase in the risk of mother-to-child transmission (3). Occult HBV infection (OBI),
characterized by the presence of very low levels of HBV DNA in blood and liver and
undetectable HBsAg levels, poses a signiﬁcant risk to individuals receiving blood
transfusions or tissue transplants (4).
In a recent systematic review and meta-analysis on the prevalence of HBV infection
in Cameroon, an overall pooled HBsAg carriage rate of 11% was reported, with a higher
prevalence in rural (13%) than in urban (9%) areas (5). Seroprevalence rates in rural
areas of Cameroon were reported for pregnant women (6, 7), Pygmy groups (8), and
HIV patients (9), whereas information on the burden of HBV in the general population,
including age-speciﬁc prevalence rates, is limited. The impact of perinatal versus
horizontal HBV transmission in African countries where the disease is hyperendemic,
like Cameroon, remains controversial (6, 7, 10, 11).
HBV isolates from around the world have been classiﬁed into nine genotypes (A to
I), most of which show a more-or-less distinct geographical distribution (12). In sub-
Saharan Africa, a predominance of genotypes A (HBV/A) and E (HBV/E) has been
reported (13–15). While HBV/E is characterized by comparatively low genetic diversity
(14), a new classiﬁcation scheme for HBV/A consisting of subgenotypes A1, A2, and A4
(previously referred to as A6) as well as quasi-subgenotype A3 (qA3; previously subdi-
vided into A3, A4, A5, and A7) was proposed (16, 17).
The HBV genome consists of a circular, partly double-stranded DNA of approxi-
mately 3,200 nucleotides and comprises four partially overlapping open reading frames
(ORFs) encoding the surface proteins (pre-S/S; corresponding to the HBsAg), the HBeAg,
and the core protein (pre-C/C), the polymerase (P), and the regulatory protein (X). The
pre-S/S ORF encodes three different, structurally related envelope proteins, which are
synthesized from alternative initiation codons and are referred to as large (L), middle
(M), and small (S) proteins, respectively (18). The pre-S/S region is the most variable part
of the HBV genome (19) and is therefore the most commonly analyzed region for
phylogenetic investigations.
According to WHO estimates, approximately 15 million of all HBsAg carriers world-
wide are chronically coinfected with hepatitis D virus (HDV) (20), a defective virus that
requires HBsAg to establish an infection. HDV infection occurs either simultaneously
with HBV or through superinfection of an HBV-positive individual. Whereas clearance of
both viruses is a common outcome of simultaneous infection, the majority of patients
with superinfection progress to chronic HDV and hepatitis (21). The prevalences of HDV
in Africa vary geographically and are particularly high in West and Central African
countries (22). In these settings, transmission of HDV through contact with the blood or
other body ﬂuids of an infected person is common (23), while the risk of vertical spread
seems to be low (20). Recent data on the HDV seroprevalence among HBsAg carriers in
Cameroon ranged from 11% (24) to 18% (25). HDV exhibits a high degree of genetic
heterogeneity and has been classiﬁed into eight different clades (1 to 8) (26), of which
clade 1 has a worldwide distribution (27). Only a few HDV genotyping studies have
been conducted in Africa. One of them reports a cocirculation of several clades (HDV-1,
HDV-5, HDV-6, and HDV-7) in Cameroon (25). HDV has a circular RNA genome of
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approximately 1,700 nucleotides, containing a single ORF encoding the hepatitis delta
antigen (HDAg) (28).
The purpose of the present study was to investigate the prevalence and genetic
diversity of HBV and HDV in the general population of a remote rural village in
Cameroon. By combining these data with available demographic information on the
study population, and by assuming that high similarity between HBV or HDV sequences
from different individuals is strongly indicative of a related source of infection, intra-
and interfamilial patterns of the transmission of these viruses were analyzed.
RESULTS
HBsAg and anti-HDV serum antibody positivity in the study population. Serum
samples from 401 of the 448 inhabitants (living in 88 households) of the village Mbandji
2 in the Bankim Rural Health Area of Cameroon were available for assessing HBV and
HDV infection prevalence. Of the 401 individuals, 222 were children under the age of
15 years. An enzyme-linked immunosorbent assay (ELISA) revealed that 13.5% of all
sera (54/401) were HBsAg positive. Between different age groups, HBsAg positivity was
highly varied, with the lowest prevalence rates recorded for young children (5 years)
and the elderly population (55 years) (Fig. 1). There was no marked gender difference
in positivity, as 12.6% (26/206) of the male and 14.4% (28/195) of the female partici-
pants tested positive. Fifteen percent (8/54) of the sera positive for HBsAg also
contained anti-HDV antibodies. Five of the HBV-HDV-coinfected individuals were adults
(one male of unknown age, two males aged 28 and 40 years, and two females aged 39
and 50 years), and three were children 9, 11, and 14 years of age.
Phylogenetic analysis of the circulating HBV and HDV variants. HBV pre-S/S
region sequences could be ampliﬁed from 91% (49/54) of the HBsAg ELISA-positive
sera. To examine the position of the genetic variants circulating in Mbandji 2 within the
global HBV phylogeny, these sequences were compared with a representative selection
of HBV sequences retrieved from GenBank (Fig. 2). While 86% (42/49) of the Mbandji 2
sequences clustered with HBV/E isolates, 14% (7/49) were closely related to HBV/A
isolates. The mean genetic distance of the 42 HBV/E pre-S/S sequences was lower
(0.7%  0.1) than that of the seven HBV/A sequences (1.2%  0.2%). HBV whole-
genome sequences could be ampliﬁed from 72% (39/54) of the HBsAg ELISA-positive
samples. Results of phylogenetic analyses of these whole genomes are consistent with
results obtained with the pre-S/S sequences (see Fig. S1 in the supplemental material).
High-resolution phylogenetic analysis of the Mbandji 2 HBV/A sequences demon-
strated that all of the seven pre-S/S sequences of this study grouped with strains
belonging to quasi-subgenotype A3 (Fig. 3A). Classiﬁcation into quasi-subgenotype A3
was conﬁrmed by whole-genome analysis of the four complete HBV/A genome se-
quences obtained (Fig. 3B).
FIG 1 Age distribution of HBsAg carriers among study participants of Mbandji 2. A stacked graph
illustrating the number of HBsAg carriers among the total number of study participants for each age
group (left y axis) is shown. Diamonds represent the percentage of HBsAg carriage for each age group
(right y axis).
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For HDV, ampliﬁcation of a 360-bp fragment of the small hepatitis D (sHD) gene
region succeeded for three of the eight samples in which anti-HDAg antibodies were
detected. Phylogenetic reconstruction together with publicly available sequences of
different HDV clades showed a clustering of the three sequences with HDV clade 1
isolates (Fig. 4).
Phylogeography and evidence for familial transmission of HBV and HDV. The
geographical distribution of the 88 studied households is depicted in a map of Mbandji
2 in the form of pie charts, corresponding in size to the numbers of study participants
(Fig. 5). The 42 study participants infected with variants of HBV/E resided in 25
households, 9 of which were inhabited by more than one HBV/E infected individual. In
order to study the spatial pattern of HBV/E variants within the village, a phylogeny of
the 49 pre-S/S sequences was constructed (Fig. 6A) (HBV/A sequences were used as an
outgroup). Dots representing the residential homes of each individual with HBV/E
sequence information in a map of Mbandji 2 (Fig. 6B) are colored according to the
corresponding branches in the HBV/E phylogenetic tree in Fig. 6A, in which information
on participant identiﬁers (IDs), household IDs, gender, family relationships, and age is
also provided. The spatial analysis revealed that in most cases, the HBV/E sequences
FIG 2 Phylogenetic reconstruction of HBV pre-S/S sequences. A maximum-likelihood phylogenetic tree of the 49
HBV pre-S/S sequences obtained in this study together with 53 publicly available sequences covering all HBV
genotypes was constructed under the general time-reversible (GTR) model G I embedded in MEGA 6.0. Of the
49 Mbandji 2 sequences, 42 (blue dots) and 7 (red dots) clustered with HBV/E and HBV/A isolates, respectively. The
tree was drawn to scale, with branch lengths measured as the number of substitutions per site. The tree was rooted
using the sequence of a woolly monkey HBV as an outgroup. There were a total of 1,212 positions in the ﬁnal data
set. Bootstrap values (80%) are shown at branch nodes.
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from infected individuals living in the same households clustered together (Fig. 6),
indicating prevailing intrahousehold transmission of HBV.
HBV/E pre-S/S sequences with high similarity were found in six of the nine house-
holds inhabited by more than one HBV/E-infected individual. This included two genetic
clusters with completely identical sequences each: one (cluster E1 in Table 1; light
green in Fig. 6) consisting of sequences from three siblings living in household A40 and
the other (cluster E2 in Table 1; dark blue in Fig. 6) comprising sequences from three
siblings living in household A6 and a couple residing in household A23, as well as ﬁve
additional individuals from ﬁve other households. Another genetic cluster (cluster E3 in
Table 1; light blue in Fig. 6) consisted of sequences from a mother with her three
children resident in household B19 as well as sequences from three additional individ-
uals from three other households. While the sequences of the mother and her two
youngest children were identical and contained two unique single-nucleotide poly-
morphisms (SNPs) that were not present in any other sequence in the entire data set,
the sequence of the oldest daughter exhibited six additional SNP differences, two of
which were uniquely found in her sequence, whereas four also occurred in the almost
identical sequence of her cousin living in household B21. It is noteworthy that the
mother tested HDV positive but that her three children were HDV negative. Sequences
from two siblings living in household A9 (cluster E4 in Table 1; red in Fig. 6) differed by
only a single SNP. They clustered together with the sequences of four additional
individuals from other households. The mother of the two siblings was HBsAg negative.
Sequences of three siblings (cluster E5 in Table 1; orange in Fig. 6) living in household
B6 were completely identical. The sequence of a fourth sibling living in this household
exhibited three unique SNPs and a 15-bp deletion that was found only in this isolate.
FIG 3 High-resolution phylogeny of HBV/A sequences. Maximum-likelihood phylogenetic trees of HBV/A pre-S/S (A) and whole-genome (B) sequences from
Mbandji 2 (red dots) together with publicly available sequences covering the described HBV/A subgenotypes were constructed in MEGA 6.0. (A) All of the seven
HBV/A pre-S/S sequences of this study clustered with strains of quasi-subgenotype A3 (qA3). Distances were calculated using the Kimura 2-parameter model
G. There were a total of 1,206 positions in the ﬁnal data set. (B) Classiﬁcation of the Mbandji 2 HBV/A sequences into qA3 was reconﬁrmed by whole-genome
analysis. Distances were calculated using the Kimura 2-parameter modelGI. There were a total of 3,221 positions in the ﬁnal data set. Both trees were drawn
to scale, with branch lengths measured as the number of substitutions per site, and were rooted using the sequence of an HBV/E strain as an outgroup (black
dot). Bootstrap values (80%) are shown at branch nodes.
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The sequences of all four siblings shared two unique SNPs that were not present in any
other sequence of the whole data set. Particularly notable is that the two female
siblings were identiﬁed to be coinfected with HDV but that the two male siblings tested
anti-HDV antibody negative.
In three of the nine households with more than one HBV/E-infected individual, no
particularly close phylogenetic relation was found between sequences of the inhabit-
ants (Fig. 6). Among these households, sequences were derived from (i) a mother (dark
blue) living in household A5 with her 11-year-old daughter (light blue), whose se-
quence was closely related to another child, (ii) an aunt (dark blue) and her niece (dark
green) resident in household A21, and (iii) a pair of siblings living in household A34
(light blue and dark green). While one of the siblings was coinfected with HDV, the
other tested anti-HDV antibody negative.
Residences of the seven individuals from whom HBV/A sequences were obtained are
distributed over the entire study area, with two of them living in the same household,
B18 (Fig. 5). These two individuals were siblings (9 and 11 years of age) and presented
with completely identical sequences (cluster A in Table 1).
In one household (B28), an HBV/E sequence was ampliﬁed from the serum of a
female and an HBV/A sequence from her male partner.
FIG 4 Phylogenetic reconstruction of HDV sequences. An unrooted maximum-likelihood phylogenetic tree of the 3 HDV sequences obtained in
this study (green dots) and 41 publicly available sequences covering all currently described HDV genotypes (1 to 8) was constructed with the GTR
model G embedded in MEGA 6.0. The three Mbandji 2 sequences clustered with strains of HDV genotype 1. The tree was drawn to scale, with
branch lengths measured as the number of substitutions per site. There were a total of 365 positions in the ﬁnal data set. Bootstrap values (80%)
are shown at branch nodes.
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The eight individuals with HDV infection were all coinfected with HBV/E; their homes
(six different households) were located mostly in the southwestern area of the village
(Fig. 5). For one of the eight HBV-HDV-coinfected individuals, no demographic infor-
mation was available.
Deduced amino acid sequence analysis. SNP sites among the 42 available HBV/E
pre-S/S sequences and the pre-C/C, X, and P sequences of the 35 complete HBV/E
genomes are listed in Table S2. Predicted amino acid sequence polymorphisms and
deletions are illustrated in Table S3.
Twenty-three of the 35 HBV/E sequences for which full genome data were available
were 3,212 nucleotides long. In-frame deletions of 1 to 5 amino acids affecting both
the pre-S2 and P regions were detected in the remaining 12 isolates. Deduced amino
acid sequences for the pre-S1 region of all 42 HBV/E pre-S/S sequences showed the
characteristic features described for genotype E isolates (29), including a length of 118
amino acids due to a single amino acid deletion in the amino terminus, the signature
motif Leu3SerTrpThrValProLeuGluTrp11, and a methionine at position 83, which intro-
duces a new translational start codon. Interestingly, another methionine at pre-S1
position 86 was present in 17 of the 42 sequences. Substitutions leading to the loss of
the pre-S2 start codon, with consequent abolishment of the M protein synthesis, were
detected in the sequences of two individuals (study participants 214 and 522). Ten
FIG 5 Geographical distribution of HBV/A, HBV/E, and HDV infections in Mbandji 2. Locations of the 88 households participating in the study are displayed
in the form of pie charts, with the pies corresponding in size to the numbers of study participants. Individuals identiﬁed as being infected with HBV/A (red)
and HBV/E (blue) or coinfected with HBV/E and HDV (green) are represented as slices in the pie charts according to their numerical proportion. No household
location is shown for study participant 490, coinfected with HBV/E and HDV, because no demographic information was available. Overview images of Cameroon
(lower left) and the Mapé Basin (lower middle) are shown to illustrate the geographical location of the study area (black rectangle). The background images,
courtesy of ESA Sentinel and the U.S. Geological Survey, are in the public domain.
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isolates, which constitute the dark-blue branch of the phylogenetic tree (Fig. 6A), had
a single amino acid deletion at pre-S2 position 22. Two isolates from individuals living
in two different households contained unique amino acid deletions of 4 and 5 amino
acids at pre-S2 positions 19 to 22 (study participant 240) and 18 to 22 (study participant
398), respectively. In the S region, all but one of the sequences had a Thr57 residue, like
the majority of isolates from northwestern Africa. In contrast, an Ile57 residue present
in the majority of HBV/E isolates from southwestern Africa (29) was detected in one
sequence belonging to a 7-year-old child (study participant 416), who was the only
HBsAg-positive individual in his household. Amino acid substitutions in the “a” deter-
minant of the major hydrophilic region, associated with immune escape, consisting of
amino acids 124 to 147 deduced from the S gene sequence (30) were identiﬁed in three
sequences at positions L127I (study participant 398), L127P (study participant 416), and
S140L (study participant 240). Analysis of the predicted amino acid sequences of the 35
HBV/E whole-genome sequences revealed that the amino acid sequence deduced from
the pre-C/C region was particularly conserved, except for the sequences of study
participants 240, 472, and 522, which contained a number of amino acid replacements
in this region (Table S3). A stop codon mutation affecting amino acid sequence position
W28* deduced from the pre-C gene region (nucleotide position G1896A in the genome
sequence), abolishing HBeAg production, was detected in two sequences (study par-
ticipants 472 and 522).
The four HBV/A sequences with complete genome information were 3,221 nucleo-
tides long with a 2-amino-acid insertion at the carboxy terminus of the core protein,
characteristic of HBV/A isolates. Of the only three SNPs detected among the four
isolates, one was nonsynonymous (amino acid position 244 in the P region), whereas
the other two were synonymous. One of the two synonymous SNPs found in three of
the four sequences was the silent G1888A (nucleotide position in the genome se-
FIG 6 Phylogeographic and transmission analysis of HBV in the population of Mbandji 2. (A) A maximum-likelihood phylogenetic tree of the 42 HBV/E and
7 HBV/A pre-S/S sequences was constructed using the Kimura 2-parameter model G to illustrate inter- and intrafamilial HBV transmission in the village.
Individuals are marked with dots colored according to different branches of the phylogenetic tree, and additional demographic information, such as participant
ID, household ID, gender, family relationships (for households with sequence information from several HBsAg carriers), and age, is shown. The tree was drawn
to scale, with branch lengths measured as the number of substitutions per site. There were a total of 1,209 positions in the ﬁnal data set. Bootstrap values
(80%) are shown at branch nodes. Asterisks indicate households in which members with identical or highly similar HBV sequences were identiﬁed (high
likelihood of intrafamilial transmission). Plus or minus signs highlight households in which family members with identical HBV sequences had differential HDV
statuses. (B) The residence of each of the study participants (except for participant 490, for whom no demographic information was available) with HBV/E
sequence information is displayed according to the color of the respective dots in the branches of the phylogenetic tree. The background image, courtesy of
ESA Sentinel, is in the public domain.
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quence) mutation, which has previously been described as a unique characteristic of
subgenotype A1 (31).
SNPs among the seven HBV/A pre-S/S sequences as well as the corresponding
deduced amino acids are listed in Table S2. All predicted polymorphic amino acid
positions detected in the pre-S/S region are illustrated in Table S3. The deduced amino
acid sequence from the pre-S1 gene region of six sequences was found to be 119
amino acids long, while that of the seventh isolate, belonging to a 35-year-old male
(study participant 203) who was the only participant of his household, contained 120
amino acids. His sequence also contained a mutation leading to the loss of the pre-S2
start codon. No deletions as well as no mutations in the “a” determinant of the major
hydrophilic region were detected in any of the HBV/A pre-S/S sequences.
No mutations in the polymerase region known to be relevant for phenotypic
resistance to the ﬁve antiretroviral drugs lamivudine, adefovir, entecavir, tenofovir, and
telbivudine were found in any of the HBV sequences.
Based on the S region amino acid sequence algorithms, Arg122, Lys160, and Leu/
Ile127, which were found in 41 HBV/E sequences, and Arg122, Lys160, Pro127, Gly159, and
Ser140, which were found in 1 HBV/E sequence (study participant 416), all HBV/E isolates
of this study were classiﬁed as serotype ayw4. All HBV/A isolates were predicted to
belong to serotype ayw1 based on their Arg122, Lys160, Pro127, and Ala159 amino acid
pattern (32).
Detection of OBI and placement of sequences in the HBV phylogeny. In order
to detect OBI in the study population, nucleic acids were extracted from the sera of 149
household contacts of the 54 HBsAg-positive individuals. Pre-S/S ampliﬁcation products
were obtained from 19 of the 149 sera. Nucleotide sequencing and phylogenetic
analysis revealed that the 19 OBI sequences were highly similar to the sequences of the
49 HBsAg-positive individuals, with 17/19 clustering with HBV/E sequences and the
remaining 2 being closely related to the HBV/A sequences identiﬁed in this study
(Fig. S2). Of the 17 occult HBV/E sequences, 5 were obtained from members of
household A6. One of the ﬁve sequences, derived from the mother, was identical to the
sequences of her three HBsAg-positive children, whereas four clustered with other
sequences. Of the remaining 12 occult HBV/E sequences, 5 were highly similar to
the sequences of their household contacts living in households A3, A9, A17, A19, and
A23, 3 (from household A15) were located on different branches of the tree, and 4 (from
households A4, A18, A35, and B9) showed no particularly close phylogenetic relation to
the sequences of their household contacts. HBsAg-positive household contacts living in
A18 and B9 were infected with HBV/A.
Of the two occult HBV/A sequences, only one was highly similar to the sequence of
the HBsAg-positive household contact living in A32, whereas the other HBsAg-positive
household contact residing in B4 was infected with HBV/E.
Highly similar phylogenetic relations were obtained by means of Bayesian analysis
(Fig. S3).
In contrast to the S regions of HBsAg-positive individuals, all of which had a Val106
residue, both of the OBI HBV/A sequences had Ile106. No amino acid variation charac-
teristic for all OBI HBV/E sequences was detected.
DISCUSSION
Despite the high endemicity of chronic HBV infection and HBV-HDV coinfection in
West and Central Africa, data on the epidemiology of these viruses in the region are
scarce, and those available are mostly from urban areas. Here, we investigated the
prevalence and genetic diversity of HBV and HDV in a remote rural population of the
Mbandji 2 community of Cameroon, for which detailed demographic information was
available to study familial relationships of transmission. A high prevalence of HBsAg
carriers (13.5%) and HBV-HDV coinfections (15%) was detected among inhabitants of
the Mbandji 2 village, mainly in individuals born in the era before Cameroon integrated
the HBV vaccine into its Expanded Program on Immunization for newborns in 2005 (33).
However, the HBsAg prevalence rate in children below the age of 5 years was still high
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(5%), which might be explained by poor access to medical care. In rural African settings,
prevention of mother-to-child transmission, requiring a combination of routine ante-
natal screening, antiviral drug treatment during pregnancy, and the integration of HBV
birth dose vaccination, needs to be implemented and improved (3). A lower HBV
prevalence in the elderly population (55 years of age) than in younger adults, as
observed in our study population, has also been described in another study (34). This
may be associated with the high mortality rate of elderly individuals infected with HBV,
presumably due to immunosenescence combined with a high prevalence of other
chronic conditions accumulated during their lifetimes (35, 36). The extremely high
HBsAg carrier rate of20% in some age groups demonstrates that public health efforts
are required to diagnose infections in the community and to ensure access to treat-
ment. None of the known drug resistance mutations was detected in any of the
analyzed HBV sequences, which might be explained by the lack of selection pressure
due to the limited use of antiviral drugs in this region.
By analyzing genomic sequences, evidence of familial transmission of HBV became
apparent for 7 of the 11 households in which more than one HBV-positive individual
was identiﬁed; identical or almost identical HBV sequences were isolated from infected
household members. It has been reported previously that apart from perinatal trans-
mission, horizontal transmission during early childhood may be a common mechanism
of HBV infection in sub-Saharan Africa (7, 10, 37). In our study, six households in which
siblings were infected with highly similar HBV/E or HBV/A sequences were identiﬁed. In
one of these (household B19), perinatal transmission from a mother to her three
children is most likely. That it is, in any case, an example of intrafamilial transmission is
proven by a genomic ﬁngerprint; the viral sequences of the mother and her two
youngest children contained two unique SNPs that were not found in any other
sequence. With respect to the involvement of the mother in intrafamilial transmission,
the situation is less clear for the other ﬁve households, in which the mother either had
OBI (household A6), was HBsAg negative (household A9), or did not participate in the
study (households A40, B6, and B18). Interestingly, the HBV pre-S/S sequence derived
from the mother with OBI of household A6 was identical to the sequences of three of
her children. Unique SNPs in almost-identical pre-S/S sequences of family members
were also identiﬁed in households A40 and B6.
Routes of HDV and HBV transmission were reported to be similar. Apart from sexual
contact, inadvertent intrafamilial spread of HDV seems to be common in regions of
high prevalence. The risk of perinatal transmission of HDV is considered to be low (38).
Anti-HDV IgG levels, which indicate exposure to HDV and persist long term, even after
viral clearance, were detected in eight study participants. In all three cases in which
HDV infections occurred in households with more than one HBsAg carrier, HDV
coinfection affected only part of the HBV-positive inhabitants. Interestingly, in two of
these (households B6 and B19), individuals with completely identical HBV sequences
had different HDV statuses. While in one family (household B6), HBV-HDV coinfection
was identiﬁed in two of four siblings, in another family (household B19), the mother,
but none of her three HBV-infected children, was coinfected. Since the sensitivity and
speciﬁcity of the applied anti-HDAg antibody kit was reported to be very high (39),
these results suggest that HDV is not necessarily transmitted together with HBV from
a coinfected donor. However, the possibility that the two siblings (household B6) and
the mother (household B19) acquired their HDV infections from different sources
cannot be ruled out completely.
Of the 49 individuals from whom HBV pre-S/S sequences were obtained in this
study, 7 and 42 belonged to genotypes A and E, respectively. The three analyzed HDV
sequences showed high similarity to other publicly available HDV clade 1 sequences.
Cocirculation of HBV/A and HBV/E genotypes (15) as well as a predominance of HDV
clade 1 infections (25) in Cameroon have been reported previously. Intragenotype
mean genetic distances of the analyzed HBV/A and HBV/E pre-S/S sequences were
determined to be 1.2% and 0.7%, respectively. Within the geographically very conﬁned
study population, the mutation rate appeared to be relatively low, since completely
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identical genomic sequences were found in inhabitants of the same households and
even in individuals living in different households (dark-blue branch of the phylogenetic
tree). A maximum of six unique SNPs were observed between the sequences of family
members with apparently linked transmission (household B19). In this household, a
mother most likely transmitted her HBV variant perinatally to her three children, which
were at the time of blood collection 3, 5, and 12 years of age. While the mother and her
two younger children exhibited completely identical sequences, the HBV strain of her
12-year-old daughter had accumulated six unique SNPs.
In two of the HBV/E sequences and in one HBV/A sequence, we detected mutations
leading to the abolishment of the pre-S2 start codon. In addition, deletions within the
pre-S2 region of 1 to 5 amino acids were identiﬁed in 19 HBV/E sequences (12 from
HBsAg-positive individuals and 7 from individuals with OBI). The pre-S2 gene is known
as the most varied region of the HBV genome, and the emergence of pre-S2 mutants
is a frequent event that may occur spontaneously or as a consequence of immune or
drug pressure (19). Several lines of evidence indicate that deletions in this region tend
to accumulate during later stages of persistent HBV infection and are associated with
different severe forms of acute and chronic liver disease (19). In our study, the
occurrence of a single amino acid deletion in completely identical sequences from 16
participants may reﬂect frequent transmission of this variant. The site of this deletion
as well as the one in three sequences with unique 4- or 5-amino-acid deletions involves
a region with known B cell epitopes (40) and is therefore indicative of the emergence
of HBV immune escape variants. The potential correlation between the pre-C mutation
G1896A, detected in two sequences of this study, and severity of liver disease remains
controversial (41).
The prevalence of HBV, particularly in rural areas of Africa remains very high.
Achieving the WHO goals of eliminating HBV (and HDV) as a public health threat by
2030 (2) will require more-effective prevention of new infections via implementation of
the HBV birth dose vaccine and improvement of vaccine coverage. Furthermore,
treatment protocols for chronic HBV infection suitable for low-income countries (42)
will have to be implemented in sub-Saharan Africa.
MATERIALS AND METHODS
Study design. Within the framework of a cross-sectional house-by-house survey for the neglected
tropical skin disease Buruli ulcer in the Mapé River Basin (Bankim District) of Cameroon, located in the
northwest Adamawa region (43, 44), serum samples from 401 of 448 inhabitants living in 88 different
households of the village Mbandji 2 were collected in January 2011. Here, we tested the 401 sera
retrospectively for the presence of HBV and HDV infection markers. Nucleic acid extraction and genome
sequencing were performed to obtain an overview of the genetic population structure of the viruses in
this region. Demographic information on the study population, including age, gender, and GPS coordi-
nates of the participants’ residences, recorded during the survey, was extracted to enable a microepi-
demiological investigation of HBV and HDV infections.
Ethics statement. Ethical clearance for the collection and testing of human blood samples was
obtained from the Cameroon National Ethics Committee (reference no. Nu172/CNE/SE/201) as well as the
Ethics Committee of Basel (EKBB, reference no. 53/11). Written informed consent was obtained from all
individuals involved in the study. Parents or guardians provided written consent on behalf of children.
ELISA testing for the presence of HBV and HDV infection markers. All serum samples were
screened for the presence of HBsAg as an indicator for an HBV infection by using the bioelisa HBsAg3.0
kit (Biokit, Barcelona, Spain) according to the manufacturer’s instructions. Serum samples with a positive
HBsAg ELISA result were subsequently analyzed with the ETI-AB-DELTAK-2 ELISA kit (DiaSorin, Saluggia,
Italy) by following the manufacturer’s protocol to test for the presence of anti-HDAg antibodies as a
marker for HDV infection. Nucleic acids were extracted from all serum samples of HBsAg-positive
individuals as well as from sera of household contacts of these individuals to enable the detection of OBI.
Nucleic acid extraction, PCR, and genome sequencing. Isolation of viral nucleic acids from 200 l
of each of the serum samples was performed by using the High Pure viral nucleic acid kit (Roche
Diagnostics, Mannheim, Germany) in accordance with the manufacturer’s instructions. Total nucleic acids
were resuspended in 50 l Tris-EDTA (TE) buffer. The ampliﬁcation of HBV whole-genome sequences was
attempted with a protocol modiﬁed from reference 45 using 4 l of the nucleic acid template, primers
P1 (5=-CCGGAAAGCTTGAGCTCTTCTTTTTCACCTCTGCCTAATCA-3=) and P2 (5=-CCGGAAAGCTTGAGCTCTT
CAAAAAGTTGCATGGTGCTGG-3=), and the following PCR proﬁle: denaturation at 94°C for 4 min followed
by 11 cycles at 94°C for 40 s, 55°C for 1 min, and 72°C for 3 min; 11 cycles of 94°C for 40 s, 60°C for 1 min,
and 72°C for 5 min; 11 cycles of 94°C for 40 s, 62°C for 1 min, and 72°C for 7 min; 11 cycles of 94°C for
40 s, 62°C for 1 min, and 72°C for 9 min; and a ﬁnal extension step at 72°C for 10 min. Samples for which
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no DNA could be ampliﬁed in the HBV whole-genome PCR were subjected to seminested PCR assays
targeting the HBV pre-S/S region (34, 46). Ampliﬁcation was attempted with 3 l of the nucleic acid
template and primer pairs PS1 (5=-CCATATTCTTGGGAACAAGA-3=) and P3 (5=-AAAGCCCAAAAGACCCA
CAA-3=) in the ﬁrst assay round and PS1 and S2 (5=-GGGTTTAAATGTATACCCAAAA-3=) in the second assay
round. We also ampliﬁed a smaller fragment spanning the S gene using primers PS1a (5=-GGAAAACAT
CACATCAGGAT-3=) and P3 for the ﬁrst round of PCR and primers PS1b (5=-AAAATTCGCAGTCCCCAACC-3=)
and P3 for the second round. Thermal conditions for all of the described PCR assays included an initial
denaturation step at 94°C for 5 min followed by 32 cycles at 94°C for 30 s, 57°C for 30 s, and 72°C for 1 min
and a ﬁnal extension step at 72°C for 10 min. All PCRs were performed using Platinum Taq DNA
polymerase and supplied reagents (Invitrogen, Carlsbad, CA) in accordance with product recommenda-
tions.
For reverse transcription of HDV RNA, 15 l of the nucleic acid template was heated to 95°C for 5 min
before being incubated with deoxynucleoside triphosphates (dNTPs) and primer 1302 (5=-GGATTCACC
GACAAGGAGAG-3=) at 70°C for 10 min. In a next step, cDNA synthesis was attempted by adding Moloney
murine leukemia virus (M-MLV) reverse transcriptase and M-MLV buffer (Sigma) to the mix and incubat-
ing it at 37°C for 50 min, followed by subjection to 94°C for 10 min. For cDNA ampliﬁcation of a 360-bp
fragment of the HDV small HD (sHD) gene sequence, nested PCR was performed with 10 l of cDNA and
primers 1302 and 853 (5=-CGGATGCCCAGGTCGGACC-3=) in the ﬁrst assay round and 5 l of the amplicon
and primers 5414 (5=-GAGATGCCATGCCGACCCGAAGAG-3=) and 5415 (5=-GAAGGAAGGCCCTCGAGAACA
AGA-3=) in the second assay round. Thermal conditions for both of the reactions included an initial
denaturation step at 94°C for 2 min followed by 35 cycles of 94°C for 30 s, 55°C for 50 s, and 72°C for
1 min and a ﬁnal extension step at 72°C for 5 min (47).
All reactions were performed in a TProfessional basic thermocycler (Biometra). PCR products were
resolved on 1% agarose gels and were puriﬁed with NucleoSpin gel and PCR cleanup kits (Macherey-
Nagel, Düren, Germany). Sequencing was done at Macrogen Inc., Europe (Amsterdam, the Netherlands)
using primers listed in Table S1.
Phylogenetic analysis of HBV and HDV isolates and inference of HBV serotypes. Genotyping of
HBV was done by analyzing either whole-genome sequences or the pre-S/S gene region. Genotyping of
HDV was based on a partial sHD gene region. Sequences were assembled using CodonCode Aligner
software version 6.0.2 (CodonCode Corporation) and were aligned with MUSCLE implemented in MEGA
version 6.0 (48). Maximum-likelihood phylogenetic analysis was performed with MEGA 6.0 after we
inferred the best DNA substitution model for the different data sets. Node support for all constructed
phylogenies was assessed with 1,000 bootstrap replicates. Reference sequences included in the phylog-
enies were retrieved from GenBank, and accession numbers are given in the respective ﬁgure legends.
MEGA 6.0 was also used to estimate the mean genetic distances among HBV sequences of the same
genotype using the Kimura 2-parameter model. Bayesian phylogenetic analysis was performed using the
birth-death migration model (BDMM; v0.2.0) (49) within the BEAST2 framework (v2.4.7). For that purpose,
we analyzed whole-genome sequences as well as pre-S/S sequences complemented with unknown
nucleotides where genetic data were missing. We labeled the samples according to their occult/active
status, where the occult cases would not be allowed to transmit. Active cases were allowed to produce
both active and occult secondary cases. We applied the general time-reversible (GTR) model with
empirical base frequencies as the substitution model and ﬁxed the mean substitution rate to 1.9E–4 (50),
allowing for some variation in the rate. The Markov chain Monte-Carlo (MCMC) algorithm was run until
60,000,000 states were sampled and 10% of the samples were discarded as burn-in. The trees were
logged on every 10,000th MCMC step, and the tree sample was summarized using TreeAnnotator as a
maximum-clade-credibility tree, with 20% of samples discarded as burn-in and median heights used as
the node heights in the tree.
Previously published mutations in HBV strains associated with “escape,” diminished antibody
binding, or phenotypic resistance to antiretroviral drugs were predicted and analyzed using the
Geno2pheno[HBV] online tool at http://hbv.geno2pheno.org/index.php.
HBV serotypes were determined on the basis of predicted amino acids at positions 122, 160, 127, 159,
and 140 of the HBsAg sequence as described previously (32) using the Web-based HBV Serotyper tool
(51), which can be accessed at http://hvdr.bioinf.wits.ac.za/SmallGenomeTools.
Data availability. All HBV pre-S/S and whole-genome sequences as well as the sequences of
fragments of the sHD gene obtained in this study were deposited in GenBank under accession numbers
MG821087 to MG821154, MH580614 to MH580652, and MH595493 to MH595495, respectively.
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